|
1
|
Tham YC, Li X, Wong TY, Quigley HA, Aung T
and Cheng CY: Global prevalence of glaucoma and projections of
glaucoma burden through 2040: A systematic review and
meta-analysis. Ophthalmology. 121:2081–2090. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Osborne NN, Chidlow G, Wood J and Casson
R: Some current ideas on the pathogenesis and the role of
neuroprotection in glaucomatous optic neuropathy. Eur J Ophthalmol
13. (Suppl 3):S19–S26. 2003.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gauthier AC and Liu J: Neurodegeneration
and neuroprotection in glaucoma. Yale J Biol Med. 89:73–79.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Almasieh M and Levin LA: Neuroprotection
in glaucoma: animal models and clinical trials. Ann Rev Vis Sci.
3:91–120. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pardue MT and Allen RS: Neuroprotective
strategies for retinal disease. Prog Retin Eye Res. 65:50–76.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lešták J, Tintěra J, Kynčl M, Svatá Z and
Rozsíval P: High tension glaucoma and normal tension glaucoma in
brain MRI. J Clin Exp Ophthalmol. 4(291)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sherman SM and Guillery RW: Exploring the
thalamus and its role in cortical function. 2nd edition MIT Press,
Boston. 2006.
|
|
8
|
Shou TD: The functional roles of feedback
projections in the visual system. Neurosci Bull. 26:401–410.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Briggs F and Usrey WM: Corticogeniculate
feedback and visual processing in the primate. J Physiol.
589:33–40. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Thompson AD, Picard N, Min L, Fagiolini M
and Chen C: Cortical feedback regulates feedforward
retinogeniculate refinement. Neuron. 91:1021–1033. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kiser PD, Golczak M, Maeda A and
Palczewski K: Key enzymes of the retinoid (visual) cycle in
vertebrate retina. Biochim Biophys Acta. 182:137–151.
2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Clements JD, Lester RA, Tong G, Jahr CE
and Westbrook GL: The time course of glutamate in the synaptic
cleft. Science. 258:1498–1501. 1992.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kew JN and Kemp JA: Ionotropic and
metabotropic glutamate receptor structure and pharmacology.
Psychopharmacology (Berl). 179:4–29. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Johnson JW and Ascher P: Voltage-dependent
block by intracellular Mg2+ of N-methyl-D-aspartate-activated
channels. Biophys J. 57:1085–1090. 1990.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Choi DW, Koh JY and Peters S: Pharmacology
of glutamate neurotoxicity in cortical cell culture: attenuation by
NMDA antagonists. J Neurosci. 8:185–196. 1988.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rothstein JD, Martin L, Levey AI,
Dykes-Hoberg M, Jin L, Wu D, Nash N and Kuncl RW: Localization of
neuronal and glial glutamate transporters. Neuron. 13:713–725.
1994.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Amara SG and Fontana AC: Excitatory amino
acid transporters: Keeping up with glutamate. Neurochem Int.
41:313–318. 2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Danbolt NC: Glutamate uptake. Prog
Neurobiol. 65:1–105. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huang YH and Bergles DE: Glutamate
transporters bring competition to the synapse. Curr Opin Neurobiol.
14:346–352. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vorwerk CK, Gorla MS and Dreyer EB: An
experimental basis for implicating excitotoxicity in glaucomatous
optic neuropathy. Surv Ophthalmol 43. (Suppl 1):S142–S150.
1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Woldemussie E, Wijono M and Ruiz G: Muller
cell response to laser-induced increase in intraocular pressure in
rats. Glia. 47:109–119. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shen Y, Liu XL and Yang XL:
N-methyl-D-aspartate receptors in the retina. Mol Neurobiol.
34:163–179. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pavlidis M, Stupp T, Naskar R, Cengiz C
and Thanos S: Retinal ganglion cells resistant to advanced
glaucoma: A postmortem study of human retinas with the carbocyanine
dye DiI. Invest Ophthalmol Vis Sci. 44:5196–5205. 2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shou T, Liu J, Wang W, Zhou Y and Zhao K:
Differential dendritic shrinkage of alpha and beta retinal ganglion
cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci.
44:3005–3010. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lestak J, Tintera J, Svata Z, Ettler L and
Rozsival P: Glaucoma and CNS. Comparison of fMRI results in high
tension and normal tension glaucoma. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 158:144–153. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fortune B, Bui BV, Morrison JC, Johnson
EC, Dong J, Cepurna WO, Jia L, Barber S and Cioffi GA: Selective
ganglion cell functional loss in rats with experimental glaucoma.
Invest Ophthalmol Vis Sci. 45:1854–1862. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Holder GE: Pattern electroretinography
(PERG) and an integrated approach to visual pathway diagnosis. Prog
Retin Eye Res. 20:531–561. 2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Parisi V, Miglior S, Manni G, Centofanti M
and Bucci MG: Clinical ability of pattern electroretinograms and
visual evoked potentials in detecting visual dysfunction in ocular
hypertension and glaucoma. Ophthalmology. 113:216–228.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nebbioso M, Gregorio FD, Prencipe L and
Pecorella I: Psychophysiological and electrophysiological testing
in ocular hypertension. Optom Vis Sci. 88:E928–E939.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lestak J, Nutterova E, Pitrova S, Krejcova
H, Bartosova L and Forgacova V: High tension versus normal tension
glaucoma. A comparison of structural and functional examinations. J
Clinic Exp Ophthalmol. S5(006)2012. View Article : Google Scholar
|
|
31
|
Castro NG, de Mello MC, de Mello FG and
Aracava Y: Direct inhibition of the N-methyl-D-aspartate receptor
channel by dopamine and (+)-SKF38393. Br J Pharmacol.
126:1847–1855. 1999.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wu Y, Pearl SM, Zigmond MJ and Michael AC:
Inhibitory glutamatergic regulation of evoked dopamine release in
striatum. Neuroscience. 96:65–72. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kaneko M, Sugawara T and Tazawa Y:
Electrical responses from the inner retina of rats with
streptozotocin-induced early diabetes mellitus. Nippon Ganka Gakkai
Zasshi. 104:775–778. 2000.(In Japanese). PubMed/NCBI
|
|
34
|
Lešták J and Rozsíval P: The influence of
corneal thickness on progression of hypertensive glaucoma. J Clin
Exp Ophthalmol. 3(245)2012. View Article : Google Scholar
|
|
35
|
Javitt DC and Zukin SR: Recent advances in
the phencyclidine model of schizophrenia. Amer J Psychiatry.
148:1301–1308. 1991.PubMed/NCBI View Article : Google Scholar
|
